Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 132.17 Million SEK | 18.46% |
| 2022 | 111.57 Million SEK | 33.68% |
| 2021 | 83.46 Million SEK | 45.32% |
| 2020 | 57.43 Million SEK | -13.96% |
| 2019 | 66.74 Million SEK | 11.93% |
| 2018 | 59.63 Million SEK | 3.26% |
| 2017 | 57.75 Million SEK | 31.11% |
| 2016 | 44.05 Million SEK | 17.06% |
| 2015 | 37.63 Million SEK | 22.56% |
| 2014 | 30.7 Million SEK | 7.93% |
| 2013 | 28.44 Million SEK | -18.51% |
| 2012 | 34.91 Million SEK | 3.37% |
| 2011 | 33.77 Million SEK | 1.77% |
| 2010 | 33.18 Million SEK | -17.31% |
| 2009 | 40.13 Million SEK | 1.7% |
| 2008 | 39.46 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 66.27 Million SEK | -5.67% |
| 2024 Q2 | 70.26 Million SEK | 3.47% |
| 2024 Q1 | 67.9 Million SEK | 92.85% |
| 2023 Q1 | 30.73 Million SEK | 8.53% |
| 2023 Q4 | 35.21 Million SEK | 7.57% |
| 2023 FY | 132.17 Million SEK | 18.46% |
| 2023 Q2 | 33.48 Million SEK | 8.95% |
| 2023 Q3 | 32.73 Million SEK | -2.25% |
| 2022 Q1 | 27.63 Million SEK | 2.18% |
| 2022 Q2 | 28.72 Million SEK | 3.94% |
| 2022 Q3 | 26.89 Million SEK | -6.36% |
| 2022 FY | 111.57 Million SEK | 33.68% |
| 2022 Q4 | 28.32 Million SEK | 5.3% |
| 2021 Q1 | 14.99 Million SEK | -27.04% |
| 2021 Q2 | 18.43 Million SEK | 22.93% |
| 2021 FY | 83.46 Million SEK | 45.32% |
| 2021 Q3 | 22.98 Million SEK | 24.71% |
| 2021 Q4 | 27.04 Million SEK | 17.64% |
| 2020 Q3 | 13.76 Million SEK | 62.52% |
| 2020 FY | 57.43 Million SEK | -13.96% |
| 2020 Q2 | 8.46 Million SEK | -42.19% |
| 2020 Q1 | 14.64 Million SEK | -22.18% |
| 2020 Q4 | 20.55 Million SEK | 49.35% |
| 2019 Q4 | 18.82 Million SEK | 17.12% |
| 2019 FY | 66.74 Million SEK | 11.93% |
| 2019 Q3 | 16.07 Million SEK | 3.3% |
| 2019 Q2 | 15.55 Million SEK | -4.51% |
| 2019 Q1 | 16.29 Million SEK | -11.52% |
| 2018 Q4 | 18.41 Million SEK | 48.51% |
| 2018 Q3 | 12.4 Million SEK | -3.18% |
| 2018 Q2 | 12.8 Million SEK | -20.02% |
| 2018 Q1 | 16.01 Million SEK | 5.38% |
| 2018 FY | 59.63 Million SEK | 3.26% |
| 2017 Q1 | 15.4 Million SEK | 36.14% |
| 2017 FY | 57.75 Million SEK | 31.11% |
| 2017 Q3 | 12.17 Million SEK | -18.7% |
| 2017 Q4 | 15.19 Million SEK | 24.8% |
| 2017 Q2 | 14.97 Million SEK | -2.8% |
| 2016 Q1 | 11.65 Million SEK | -3.23% |
| 2016 Q2 | 10.29 Million SEK | -11.7% |
| 2016 Q4 | 11.31 Million SEK | 4.89% |
| 2016 Q3 | 10.79 Million SEK | 4.86% |
| 2016 FY | 44.05 Million SEK | 17.06% |
| 2015 Q4 | 12.04 Million SEK | 78.61% |
| 2015 Q3 | 6.74 Million SEK | -30.59% |
| 2015 Q2 | 9.71 Million SEK | 6.33% |
| 2015 Q1 | 9.13 Million SEK | 2.65% |
| 2015 FY | 37.63 Million SEK | 22.56% |
| 2014 Q4 | 8.89 Million SEK | 27.97% |
| 2014 Q1 | 7.69 Million SEK | 19.3% |
| 2014 Q2 | 7.15 Million SEK | -7.02% |
| 2014 Q3 | 6.95 Million SEK | -2.81% |
| 2014 FY | 30.7 Million SEK | 7.93% |
| 2013 FY | 28.44 Million SEK | -18.51% |
| 2013 Q4 | 6.45 Million SEK | -3.27% |
| 2013 Q3 | 6.66 Million SEK | -5.66% |
| 2013 Q2 | 7.06 Million SEK | -14.41% |
| 2013 Q1 | 8.25 Million SEK | 1.15% |
| 2012 FY | 34.91 Million SEK | 3.37% |
| 2012 Q2 | 8.12 Million SEK | -15.28% |
| 2012 Q3 | 9.03 Million SEK | 11.2% |
| 2012 Q4 | 8.16 Million SEK | -9.63% |
| 2012 Q1 | 9.58 Million SEK | 29.6% |
| 2011 Q4 | 7.39 Million SEK | -3.18% |
| 2011 Q1 | 10.4 Million SEK | -0.94% |
| 2011 FY | 33.77 Million SEK | 1.77% |
| 2011 Q3 | 7.64 Million SEK | -8.23% |
| 2011 Q2 | 8.32 Million SEK | -19.97% |
| 2010 Q2 | 6.77 Million SEK | -9.88% |
| 2010 Q1 | 7.51 Million SEK | -35.58% |
| 2010 Q3 | 8.39 Million SEK | 23.86% |
| 2010 Q4 | 10.5 Million SEK | 25.2% |
| 2010 FY | 33.18 Million SEK | -17.31% |
| 2009 Q1 | 11.17 Million SEK | 0.0% |
| 2009 Q3 | 7.37 Million SEK | -25.58% |
| 2009 Q2 | 9.91 Million SEK | -11.35% |
| 2009 FY | 40.13 Million SEK | 1.7% |
| 2009 Q4 | 11.66 Million SEK | 58.22% |
| 2008 Q2 | 6.72 Million SEK | -36.03% |
| 2008 Q1 | 10.51 Million SEK | 0.0% |
| 2008 FY | 39.46 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -2395.205% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 56.031% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 56.031% |
| Arcoma AB | 11.07 Million SEK | -1093.849% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | 5.579% |
| BICO Group AB (publ) | 1.83 Billion SEK | 92.78% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 47.071% |
| CellaVision AB (publ) | 463.04 Million SEK | 71.456% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -4310.11% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 565.16% |
| C-Rad AB (publ) | 66.01 Million SEK | -100.214% |
| Duearity AB (publ) | -4.17 Million SEK | 3263.499% |
| Dignitana AB (publ) | 58.97 Million SEK | -124.129% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 416.199% |
| Getinge AB (publ) | 13.43 Billion SEK | 99.016% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 363.198% |
| Iconovo AB (publ) | 17.57 Million SEK | -651.926% |
| Integrum AB (publ) | 690.56 Thousand SEK | -19039.628% |
| Luxbright AB (publ) | -2.79 Million SEK | 4825.665% |
| Mentice AB (publ) | 236.38 Million SEK | 44.086% |
| OssDsign AB (publ) | 83.64 Million SEK | -58.014% |
| Paxman AB (publ) | 12.61 Million SEK | -947.48% |
| Promimic AB (publ) | 38.51 Million SEK | -243.168% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 360.42% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -724.163% |
| ScandiDos AB (publ) | 47.55 Million SEK | -177.933% |
| Sectra AB (publ) | 557.55 Million SEK | 76.294% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -21.279% |
| Senzime AB (publ) | 8.33 Million SEK | -1484.974% |
| SpectraCure AB (publ) | -9.22 Million SEK | 1533.059% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 93.318% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 68.298% |